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ABSTRACT 
The purpose of this research was to  evaluate, by means of in vivo studies, the efficacy of new 
cosmetic active ingredients which effect of botox, called Argireline®), so that width and depth of 
wrinkles could be established. For this, it is prepared two formulations: an emulsion with an external 
aqueous phase for normal to dry skin, and a gel for oily skin. We likewise study the water content of 
the skin after the application of both formulas, as this must be one of the priority functions of facial 
treatments in general, as well as the level of satisfaction from the subjective point of view, 
fundamental for patients and their continuation of the treatment. 
After the designed tests, it is possible to verify that there is a remarkable diminution of the wrinkles 
size tested in each patient during the month of treatment. Besides, it is possible to review how the 
moisturizing capacity has been increased in all cases. 
At the end of the visual test, all the volunteers experienced a reduction in the depth of wrinkles, and 
from the subjective point of view, the appearance and elasticity of the skin were improved. Finally  it 
is possible to conclude that Argireline® (acetyl hexapeptide-8 ) shows a great antiaging capacity in all 
the cases that have been studied and the tried compounds have increased  moisturizing power. 
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 INTRODUCCIÓN 
Independently of the physiological origin of wrinkles, the molecular mechanism involved in the 
ageing of the skin is directly related to changes in the formation of the triple helix of collagen, the 
deterioration of the polypeptides of elastin, and disorder in the packing of the skin’s lipid matrix. In 
other words, skin ageing involves a slow impairment of the cellular functions and thus atrophy of the 
skin in both the epidermis and the dermis1. However, in recent years, it has been demonstrated that the 
contractions that appear in the membranous septa of the connective tissue can be responsible for 
expression lines2. In this regard, favourable results with botulin toxin infiltration led to the 
development of a new active principle with effects similar to the botox effect, named Argireline®, as 
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an alternative to botulinum toxin.  
The cosmetic possibilities of botulinum toxin were first realised in 1987, when an improvement in the 
expression wrinkles of the brow was noted after treating a patient with blepharospasm, though the first 
publications on the treatment of wrinkles on the glabella and the peri-ocular region did not appear until 
the start of the nineties3,  and subsequently its usefulness was demonstrated on other areas of the face 
and neck4. However, there are adverse local effects as a result of puncture (pain, erythema, oedema) 
and diffusion of the toxin (ptosis of the eyelids and eyebrows, asymmetry of the smile, flaccidity, 
difficulty in speaking)5. 
The search for new compounds to prevent or attenuate skin aging and enhance self-image6 is a priority 
of current research on active cosmetics.  
However, and despite the great number of substances that promise rejuvenation of the skin produced 
by the cosmetics industry, very few of them seem to truly have an effect on the skin7. Given the social 
implications surrounding physical appearance, the main aim of this work is to verify the effect of the 
active cosmetic ingredient, Argireline®, in different types of formulations: gel and cream, which are 
applied to oily and dry skins, respectively, on women aged between 40 and 57. Likewise, the degree of 
moisturisation and patient satisfaction of both preparations were studied. 
Material and Methods 
Material 
The products used as components in our formulations were: 
Argireline® (acetyl hexapeptide-8), Batch F1460/04, supplied by Lipotec (Barcelona, Spain). 
Neo PCL o/w Autoemulsionable® (cera alba, stearyl heptanoate, cetearyl octanoate, cetyl palmitate, 
stearyl alcohol, steareth-7, steareth-10, stearyl caprylate, isopropyl myristate, myristyl alcohol, 
dimethicone, paraffinum liquidum, Batch 0512651, supplied by Roig Farma-Fagron (Terrasa, Spain). 
Tefose 2561: (PEG-6 stearate, Ceteth-20, Glyceryl stearate, Steareth-20, Batch 0503697, supplied by 
Roig Farma-Fagron (Terrasa, Spain). 
Cyclomethicone pentamer (cyclopentasiloxane), purity 99.26%, Batch 0509565, supplied by Roig 
Farma-Fagron (Terrasa, Spain). 
Sorbitol 70%, Ph. Eur., purity 70.1%, Batch 0405020, supplied by Roig Farma-Fagron (Terrasa, 
Spain).  
Glycerol Ph. Eur., purity 99.8%, Batch 05F0204, supplied by Roig Farma-Fagron (Terrasa, Spain). 
Hispagel 200®, Batch 0409242, supplied by Roig Farma-Fagron (Terrasa, Spain). 
Propylene glycol Ph. Eur., water content <0.1%, Batch 04K23FP, supplied by Roig Farma-Fagron 
(Terrasa, Spain). 
Phenonip® (phenoxyethanol, methylparaben, butylparaben, ethylparaben, propylparaben), Batch 
0510592, supplied by Roig Farma-Fagron (Terrasa, Spain). 
Kathon CG® (methylchloroisothiazolinone 1.5%, methylisothiazolinone 0.37%), Purity 75.2%, Batch 
0504885, pH 2.6.  
Deionized distilled water, supplied by Interapothek (Murcia, Spain). 
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Methods 
1.Preparation of formulations 
Was prepared an oil/water emulsion for normal-to-dry skin and a cream for oily skin. The used 
technique was the same one that the published study8.  
Both formulations were stored at room temperature (25 ºC). 
2. In Vivo Trial: Hydrating and Anti-Wrinkling Efficacy 
The measurement apparatus was Clinipro Antiaging SD, using the IMAGE DB system, which makes 
it possible to determine both the width and depth of the wrinkles. The first day of the trial and prior to 
the application of the formulations, the depth and width of a given wrinkle were measured, which 
would be the same throughout the study  period. In addition, it has a flat probe with surface area of 
1.5cm2, which is applied at constant pressure on the skin. This probe determines the amount of water 
present in the surface layers of the skin.  
From the values obtained, the percentage of reduction during the study period was calculated. 
Photographs were also taken of these wrinkles on all the volunteers before starting the test and after 30 
days of application of the product. The images were taken of the wrinkles under study with facial 
scanner that processes the images taken of the wrinkles under study, which were subsequently 
processed by software.  
A fixed amount of the studied formulation was deposited, by means of syringe, onto the entire 
surface of the faces of 20 volunteers aged between 40 and 57 years. The face was then gently 
and uniformly massaged for approximately 30 seconds, until complete absorption of the 
formulation. 
The volunteers were divided into two groups, those with dry skin and those with oily skin, 50% of the 
volunteers in the study had oily skin and the other 50% dry skin. 
The study was always carried out by the same person in order to reduce possible experimental 
errors, and throughout the trial period the volunteers undertook not to use any other type of 
preparation except that under study, twice a day. 
The environmental conditions were between 23-25ºC and relative humidity of 60%. 
Two types of trials were carried out9: It was studied whether the two formulations could affect 
the aqueous content of the skin and the evolution of the wrinkle, in the short-term and long-
term. 
Short-term trial: the formulas were applied every 12 hours and measurements were taken 24 
hours after application. 
Long-term trial: To do this, the volunteers were treated with the cream or gel for one month, 
twice a day. The evolution of the aqueous content of the skin was determined after 7, 15, 21 and 
30 days. 
3. Sensorial Evaluation 
The subjectivity of the evaluator may condition the evaluation of a cosmetic10,  and may even 
lead to interruption in the use of it. Therefore, in order to obtain their personal perceptions, the 
volunteers were asked about both the product during its application and its action at the end of 
the study11. 
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The tests carried out were: 
- Acceptability of the products based on the absence or presence of sensorial properties. The 
organoleptic characteristics were evaluated in accordance with the following descriptive 
terminology12: thick, hard, creamy, smooth, soft,dry, thin, spreadable, cool or warm.  
- Adequacy13: this was assessed by the patients themselves, who classified them within 
the following categories: Satisfactory, Passable, Non-satisfactory.  
- Improvement in the texture and elasticity of the skin: evaluated in terms of the 
appearance and feel of the skin, assigning one of the following categories: Very Good, 
Good, Passable, Bad.  
The parameters were visually assessed by the researchers. 
The researchers assigned points to the reduction in the wrinkles, comparing each time point 
with the photograph taken at the start of the study: 1. No reduction, 2. Slight reduction, 3. Medium 
reduction, 4. Considerable reduction 
Results and Discussion 
Three determinations were carried out on each volunteer. The average values and the standard 
deviation were calculated for each one of the trials. All the results underwent an Anova statistical 
treatment to give a confidence level of 95%, in order to check whether there were any significant 
differences between the averages compared.  
1. In Vivo Trial: Hydrating and Anti-Wrinkle Efficacy 
Moisturisation Test: 
Figure 1. Evolution of the wrinkle depth on dry skin (a) and oily skin (b). 
 
The increase in the water content was immediate, appearing in all cases after 24 hours. The skin 
Ars Pharm, Vol. 50 nº4; 168-176 
RUIZ MA. Evaluation of the anti-wrinkle efficacy of cosmetic formulations…  172 
moisturisation values increased considerably in both the short- and long-term studies, varying, at the 
end of these, between 11.43%-64.28% and 35.71-81.43%, for dry and oily skins, respectively. It was 
noted that in some patients the aqueous content on the first days of the treatment was greater than that 
obtained on successive days.  
In the course of the study, there was a progressive increase in the moisturisation level of the 
face. The differences noted between zero hours and 24 hours, 15 and 30 days after the 
application of the cream or gel, are shown in figure 1 as a % of moisturisation gained over the 
course of the two trials. The greatest increase over the course of the study was after 30 days, 
with the exception of one patient for each skin type. The results show how, at the end of the 
study, the aqueous content of the skin had increased in all the patients, compared to day 0, with 
values of between 9.65 - 63.54 and 10.33 -53.02, for dry and oily skins, respectively.  
Anti-Wrinkle Test 
Figure 2 show the evolution in the depth and width of the wrinkles for both formulations. Particularly 
notable is the reduction in depth compared to the reduction in width of the wrinkles. However, the 
results show a reduction in both parameters after 30 days of treatment. The values of depth of the 
wrinkle reduced significantly in both the short-term and long-term studies. The same is not true for the 
width, as in the majority of patients with dry skin, the differences in width over time are not very 
significant. In patients with oily skin, these differences were only relevant after 30 days of treatment. 
Despite this, reductions were achieved in the width, which varied between 8.36 - 75.17% and 11.85 - 
88.88 %, for dry and oily skin, respectively. 
On the other hand, there was a clear reduction in the depth 24 hours after the application, compared to 
the start. After one week, this difference had increased. The same was true after 15, 21 and 30 days. 
The greatest difference in the reduction of the depth of the wrinkle was after 30 days, with reductions 
of between 41.83 - 77.79% and 64.16 - 78.25 %, for dry and oily skins, respectively. 
In general, and in accordance with the results obtained, the values of cutaneous moisturisation, depth 
and width of wrinkle were slightly more favourable for the volunteers with oily skin. 
The appearance of the skin depends on its general condition, and in particular its level of 
moisturisation, as this regulates the elasticity, flexibility and smoothness of the skin14-16.  
The integrity of the extracellular matrix, especially the collagen fibres, is essential to ensure that the 
epidermis is firmly anchored to the dermis. It has been suggested that the deterioration of the collagen 
fibres, at the dermis-epidermis union, weakens it, which finally leads to the appearance of wrinkles17-
18. 
In expression wrinkles, the contraction of the muscle leads to contraction of the fibroblasts and with 
this the contraction of the collagen fibres and even deterioration of the extracellular matrix in the 
affected area. Consequently, the hydrating properties of all the components of the matrix will be 
affected.  
According to the results obtained in the moisturisation and anti-wrinkle tests and based on the 
bibliography consulted regarding the action mechanism of Argireline19,  it could be said that it is 
capable of relaxing the fibroblasts, which will decontract the collagen and elastin matrix, which could 
be decisive in preventing deterioration of the functions of collagen, such as water retention. Thus, it 
could be deduced that by reducing the wrinkle, greater moisturisation is achieved. 
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Figure 2. Differences in reduction of depth compared to day 0 for dry skins (a) and oily skins (b). 
 
 
 
2. Sensorial Evaluation 
Favourable results were obtained for both formulas: 
With regard to the organoleptic characteristics of the preparations, all the patients classified 
them as satisfactory. All of them described the cream as smooth, creamy and spreadable, and 
the gel as smooth, soft and cool. 
From the subjective point of view, the appearance and elasticity of the skin were improved.  
Figure 3 are photographs of a wrinkle of volunteers with dry and oily skin, respectively, taken at the 
start and after 30 days of treatment. In the photographs, is possible to observe that the formulations 
studied improve the appearance of the wrinkles. 
Table I shows both the points and the statistical analysis of the visual evaluation of the reduction in 
depth and width. The average variation in the depth of the wrinkle is given in figure 4. The Friedman 
test was used.  
The qualitative reduction of the wrinkles was determined, obtaining improvements in 90 and 100% of 
the volunteers, with dry and oily skin, respectively. According to Friedman test, the data obtained after 
15 and 30 days are significant (Table II). At the end of the visual test, all the volunteers experienced a 
reduction in the depth of wrinkles. 
 
Ars Pharm, Vol. 50 nº4; 168-176 
RUIZ MA. Evaluation of the anti-wrinkle efficacy of cosmetic formulations…  174 
 
Figure 3. Photograph of the wrinkle of a volunteer with dry skin (0 day-A); (30 day-B). Oily skin (0 
day-C); oily skin (30 day-D). 
 
 
 
 
Figure 4. Visual evaluation of average variation in wrinkle depth. 
 
 
 
Table I. Visual evaluation of variation in wrinkle depth. 
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Table II. Visual evolution of wrinkle depth. 
 
Conclusions 
In accordance with the visual analyses of the photographs and the studies of depth and width, it was 
verified that there was a notable reduction in the dimensions of the wrinkle studied in each patient 
during the month of treatment. Likewise, the level of moisturisation increased in all cases. 
The differences observed between the untreated and treated skin were always significant. The 
results demonstrate that, over the course of the trial, there was a progressive increase in the 
level of moisturisation, as well as a progressive reduction in the depth and width of the 
wrinkle compared to day 0. 
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